Received: September 23, 2011; Accepted: October 20, 2011.
Share :
ABSTRACT
Purpose : Peritoneal cytology has been reported to be a useful tool for the detection of peritoneal dissemination in
several studies, and in the 7th edition of the AJCC staging, positive peritoneal cytology is classified as metastatic
disease. This study evaluated the presence of free cancer cells through the peritoneal cytology in gastric cancer
patients and analyzed their clinical and prognostic values.
Materials and Methods : Total 125 gastric cancer patients who underwent gastrectomy with intraoperative
peritoneal cytology were enrolled in this study, and they were categorized into two groups; cytology negative (Cy-)
and cytology positive (Cy+).
Results : 16 of total 125 patients (12.8%) were Cy+, and they had more advanced T, N, and M stages, as well as
histologically undifferentiated carcinomas. The difference of the overall survival rates between Cy- and Cy+ group
was not significant (p =0.106), but the disease free survival rates of patients with Cy+ were significantly shorter
than those with Cy- (p <0.001). The survival curves of patients with positive cytology but no gross metastasis
(Cy+/M0) showed no significant difference, compared to those with gross metastasis (M1) (p =0.076).
Conclusions : Peritoneal lavage cytology may be a useful marker of tumor progression and a strong predictor of
recurrence in gastric cancer patients. However, it should be questioned whether this novel marker is an
independent prognosticator in survival and recurrence.